SCHEDULE: Equifax Stake: Capital International Investors Holds 3.2%

Capital International Investors reports a 3.2% stake in Equifax Inc. as of March 31, 2026, holding 3,820,844 shares.

Summary

• Capital International Investors (CII) has filed a Schedule 13G, indicating beneficial ownership of Equifax Inc. common stock.
• As of March 31, 2026, CII beneficially owns 3,820,844 shares of Equifax Inc. common stock.
• This represents 3.2% of the total class of securities outstanding.
• CII has sole voting power over 3,770,571 shares and sole dispositive power over 3,820,844 shares.
• Capital International Investors is a division of Capital Research and Management Company and its affiliates.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership by an institutional investor and does not contain new operational or financial information.

Positives

• Capital International Investors, a significant investment management entity, holds a notable stake in Equifax.
• The filing indicates a stable ownership position with clear voting and dispositive power over the reported shares.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors disclosing significant ownership stakes. This filing confirms Capital International Investors' position as a substantial shareholder in Equifax, a key player in the credit reporting and data analytics industry.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional investor's stake, which can influence market perception and trading activity.
• Management: The disclosure provides transparency regarding major shareholders, which is a standard aspect of corporate governance.

Key Dates

Keywords

Equifax, Schedule 13G, Capital International Investors, beneficial ownership, common stock, investment management, SEC filing